EMQN have recently undergone an organisational review, and as a result our membership scheme is evolving and adapting to fit in with both the needs of our members and our organisation. From 2022, we will be offering our membership at no yearly cost.
Click below to read EMQN’s full statement on our membership scheme changes as well as what’s new for 2022!
Schemes for 2022 will be available for purchase at the end of September 2021. In the mean time, our scheme catalogue is available to view.
Please click the link below to visit our scheme catalogue to preview the schemes for the upcoming 2022 year.
We provide ISO 17043 accredited External Quality Assessment (EQA) or Proficiency Testing (PT) schemes which are designed to test the whole analytical process of a molecular diagnostics laboratory including the ability to interpret data in the light of clinical information supplied with a referral, and to produce a clear and accurate report.
We have EQAs for SARS-Cov-2 only, or in conjunction with other major respiratory viruses (RSV, Influenza) available for registration. Use the button below to browse our scheme catalogue.
Membership of EMQN gives your laboratory access to world class resources in genomics to help improve your performance.
We've listened to your feedback and have updated our 2022 membership scheme... - https://t.co/RNXA4uwie9
The Deadline for Submitting Appeals for the 2021 Germline Schemes is Approaching - https://t.co/RDjpMU0ok4
Reminder - Deadline rapidly approaching for submitting results for 2021 Molecular Pathology and Technical EQA schem… https://t.co/W3bgywPdXl
Opportunities available: Are you interested in sharing good practice and shaping the quality of diagnostic genomic… https://t.co/Uuj2MW5rpF
Webinar Series Now Available – Ensuring Accurate Classification of BRCA1 and BRCA2 Variants -… https://t.co/gUq4i89riM